[go: up one dir, main page]

MX2010007011A - Composicion para alimentacion humana y/o animal, sus usos, y levaduras. - Google Patents

Composicion para alimentacion humana y/o animal, sus usos, y levaduras.

Info

Publication number
MX2010007011A
MX2010007011A MX2010007011A MX2010007011A MX2010007011A MX 2010007011 A MX2010007011 A MX 2010007011A MX 2010007011 A MX2010007011 A MX 2010007011A MX 2010007011 A MX2010007011 A MX 2010007011A MX 2010007011 A MX2010007011 A MX 2010007011A
Authority
MX
Mexico
Prior art keywords
human
yeasts
animal nutrition
composition
yeast
Prior art date
Application number
MX2010007011A
Other languages
English (en)
Inventor
Jean-Luc Simon
Georges Pignede
Pascal Vandekerckove
Daniel Poulain
Pierre Desreumaux
Arlette Darfeuille-Michaud
Adeline Sivignon
Original Assignee
Lesaffre & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0801342A external-priority patent/FR2928652B1/fr
Application filed by Lesaffre & Cie filed Critical Lesaffre & Cie
Publication of MX2010007011A publication Critical patent/MX2010007011A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C12N1/185—Saccharomyces isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

La presente invención se refiere a nuevas cepas de levadura, levaduras obtenidas de estas cepas, una composición que comprende al menos una levadura Saccharomyces cerevisiae y/o derivados de levadura que presenta un interés concreto como complemento alimentario y/o producto probiótico y/o producto funcional y/o producto nutracéutico y/o ingredientes funcionales y/o producto cosmecéutico y/o principio activo farmacéutico. Se refiere igualmente a su uso en la alimentación humana y/o animal o para el tratamiento o la prevención de patologías inflamatorias.
MX2010007011A 2007-12-26 2008-12-12 Composicion para alimentacion humana y/o animal, sus usos, y levaduras. MX2010007011A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0760377 2007-12-26
FR0801342A FR2928652B1 (fr) 2008-03-12 2008-03-12 Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
PCT/FR2008/001729 WO2009103884A2 (fr) 2007-12-26 2008-12-12 Composition pour l'alimentation humaine et/ou animale, ses utilisations, levures

Publications (1)

Publication Number Publication Date
MX2010007011A true MX2010007011A (es) 2010-10-13

Family

ID=40985983

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010007011A MX2010007011A (es) 2007-12-26 2008-12-12 Composicion para alimentacion humana y/o animal, sus usos, y levaduras.

Country Status (24)

Country Link
US (1) US8476058B2 (es)
EP (1) EP2227539B1 (es)
JP (1) JP5497661B2 (es)
KR (1) KR101654537B1 (es)
CN (1) CN101918536B (es)
AU (1) AU2008351156B2 (es)
BR (1) BRPI0820068B8 (es)
CA (1) CA2709850C (es)
DK (1) DK2227539T3 (es)
ES (1) ES2649914T3 (es)
HR (1) HRP20171632T1 (es)
HU (1) HUE034628T2 (es)
IL (1) IL206110A (es)
LT (1) LT2227539T (es)
MX (1) MX2010007011A (es)
MY (1) MY159379A (es)
NO (1) NO2227539T3 (es)
NZ (1) NZ586417A (es)
PL (1) PL2227539T3 (es)
RU (1) RU2490324C2 (es)
SI (1) SI2227539T1 (es)
TN (1) TN2010000239A1 (es)
WO (1) WO2009103884A2 (es)
ZA (1) ZA201003978B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876798A1 (fr) * 2004-10-14 2006-04-21 Univ Clermont Auvergne Diagnostic et traitement de la maladie de crohn
HRP20171632T1 (hr) 2007-12-26 2017-12-15 Lesaffre Et Compagnie Pripravak za ljudsku i/ili životinjsku ishranu, njegova upotreba i kvasci
FR2949043B1 (fr) * 2009-08-17 2013-05-17 Lesaffre & Cie Pate boulangere fermentee tolerante a l'appret
EP2682122A4 (en) * 2011-03-04 2014-07-23 Lion Corp GROWTH HORMONE SEKRETIONSPROMOTER
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
FR2993179B1 (fr) 2012-07-13 2016-01-08 Lesaffre & Cie Levure saccharomyces cerevisiae pour prevenir et/ou traiter les mycoses vaginales
WO2015061798A2 (en) * 2013-10-25 2015-04-30 R.F. Technology Consultants, Inc. Compositions and methods comprising yeast organisms and lipid extracts thereof
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
KR101837160B1 (ko) 2016-07-20 2018-03-09 서울대학교산학협력단 신균주 bt-sjp kctc12726bp 및 이의 용도
WO2018052082A1 (ja) * 2016-09-14 2018-03-22 株式会社Ｔｅｓホールディングス Ｌｉｎ２８ａ活性化剤及びその使用
US11523625B2 (en) 2017-08-07 2022-12-13 Techmix, Llc Feed supplement bolus with active yeast
CN109536370A (zh) * 2018-12-10 2019-03-29 浙江华康药业股份有限公司 一种体外发酵糖醇益生功能评价装置及方法
FR3089788B1 (fr) 2018-12-17 2020-12-18 Lesaffre & Cie Souche de levure Saccharomyces cerevisiae pour le traitement et/ou la prévention de candidoses oropharyngées
FR3090318B1 (fr) * 2018-12-19 2024-06-14 Lesaffre & Cie Souche Saccharomyces cerevisiae var boulardii en santé orale
DK3685681T3 (da) 2019-01-23 2024-09-02 Lesaffre & Cie Gærprodukt, og sammensætning omfattende det, til anvendelse som et præbiotisk middel
FR3096891B1 (fr) 2019-06-04 2022-05-13 Lesaffre & Cie Composition pour la prevention de la cystite simple et/ou recidivante
CN112273657A (zh) * 2019-07-22 2021-01-29 安琪酵母股份有限公司 用于预防或改善过敏性疾病的益生菌组合物、制法和应用
KR102275115B1 (ko) * 2019-10-16 2021-07-07 한국식품연구원 프로바이오틱 활성을 갖는 사카로마이세스 세레비지애 보울라디­０３ 신균주 및 이의 용도
FR3120789B1 (fr) 2021-03-16 2024-01-19 Lesaffre & Cie Inhibiteurs glycosidiques de levure
MX2023015498A (es) 2021-06-30 2024-03-04 Ab Mauri Uk Ltd Composiciones de levadura fisiologicamente aceptables y usos de las mismas.
CN118541038A (zh) * 2021-06-30 2024-08-23 英联马利(英国)有限公司 生理学上可接受的酵母菌组合物及其用途
FR3134581A1 (fr) * 2022-04-15 2023-10-20 Lesaffre Et Compagnie Levure Saccharomyces cerevisiae et son utilisation pour améliorer la santé intestinale des animaux de compagnie.
WO2025115611A1 (ja) * 2023-11-30 2025-06-05 株式会社日清製粉グループ本社 免疫調節剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
RU2233320C2 (ru) * 2001-02-13 2004-07-27 Гриневич Владимир Борисович Способ получения биологически активного препарата, биологически активная добавка (бад) к пище пребиотического действия, приводящая к коррекции (нивелированию) метаболического синдрома и лекарственный препарат для регуляции микробиоценоза желудочно-кишечного тракта
WO2006021965A1 (en) * 2004-08-23 2006-03-02 Bharat Biotech International Limited Eukaryotic based synergistic formulation for gastro-intestinal disorders
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
US7498367B2 (en) * 2005-02-21 2009-03-03 Kerr Corporation Acid-tolerant dental composition
FR2928652B1 (fr) 2008-03-12 2013-11-15 Lesaffre & Cie Composition pour l'alimentation humaine et/ou animale,ses utilisations,levures
HRP20171632T1 (hr) 2007-12-26 2017-12-15 Lesaffre Et Compagnie Pripravak za ljudsku i/ili životinjsku ishranu, njegova upotreba i kvasci

Also Published As

Publication number Publication date
CN101918536A (zh) 2010-12-15
BRPI0820068B8 (pt) 2021-07-27
NO2227539T3 (es) 2018-01-06
WO2009103884A2 (fr) 2009-08-27
CN101918536B (zh) 2013-07-03
JP5497661B2 (ja) 2014-05-21
KR101654537B1 (ko) 2016-09-06
WO2009103884A3 (fr) 2009-12-17
CA2709850A1 (fr) 2009-08-27
RU2490324C2 (ru) 2013-08-20
AU2008351156B2 (en) 2013-10-17
BRPI0820068B1 (pt) 2020-03-17
RU2010131018A (ru) 2012-02-10
ES2649914T3 (es) 2018-01-16
IL206110A0 (en) 2010-11-30
EP2227539B1 (fr) 2017-08-09
MY159379A (en) 2016-12-30
ZA201003978B (en) 2012-02-29
LT2227539T (lt) 2017-11-27
DK2227539T3 (da) 2017-11-13
AU2008351156A1 (en) 2009-08-27
TN2010000239A1 (fr) 2011-11-11
US20100303778A1 (en) 2010-12-02
BRPI0820068A2 (pt) 2015-09-01
SI2227539T1 (en) 2018-03-30
HUE034628T2 (hu) 2018-02-28
NZ586417A (en) 2012-07-27
IL206110A (en) 2013-07-31
EP2227539A2 (fr) 2010-09-15
HRP20171632T1 (hr) 2017-12-15
JP2011509651A (ja) 2011-03-31
US8476058B2 (en) 2013-07-02
CA2709850C (fr) 2018-03-20
PL2227539T3 (pl) 2018-01-31
KR20110066118A (ko) 2011-06-16

Similar Documents

Publication Publication Date Title
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2012087742A3 (en) Methods and compositions suitable for managing blood glucose in animals
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2011148328A3 (en) Cosmetic process for making-up and/or caring for the skin and/or the lips
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EP4302834A3 (en) 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
WO2012024620A3 (en) Autotaxin inhibitors and uses thereof
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2007141392A3 (en) Compositions comprising betulonic acid
WO2010129285A3 (en) Antimicrobial compositions and related methods of use
WO2008036932A3 (en) Compositions and methods comprising boswellia species
WO2013175221A3 (en) Composition
EP1941892A3 (en) Anti-allergy lactic acid bacteria
WO2012001074A3 (en) Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate
WO2012040804A3 (en) Synergistic combinations of triazoles, strobilurins and benzimidazoles, uses, formulations, production processes and applications using the same
WO2009066537A1 (ja) 免疫調節性機能誘導剤及び食品組成物
WO2010041832A3 (ko) 패 유래 화합물 함유 항산화 활성 조성물
NZ612732A (en) Hop oxidation-reaction product, preparing method thereof and use thereof
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
WO2008057300A3 (en) Trpvi antagonists and uses thereof
WO2011043631A3 (ko) 호장근 추출물, 이의 분획물 또는 스틸벤계 화합물을 포함하는 감기의 예방 및 치료용 약학 조성물
WO2009038095A1 (ja) セサミン類とビタミンｂ１類とを配合した組成物
MX2014010565A (es) Eliminacion de nota de sabor oxidado en comestibles.
MX2023015507A (es) Composiciones de levadura fisiologicamente aceptables y usos de las mismas.

Legal Events

Date Code Title Description
FG Grant or registration